Developing a CAR-T for Autoimmune Disease Clinical Program Effectively
Time: 1:00 pm
day: Conference Day Two
Details:
- Discussing background and outcomes using CAR-T cells in hematological malignancies
- Developing a multidisciplinary program to administer CAR-T cell therapies for noncancer indications
- Identifying challenges when using CAR-T cells in autoimmune diseases rather than in B-cell malignancies
